ClinicalTrials.govpublic full text
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease
nonalcoholic fatty liver, nonalcoholic steatohepatitis, elobixibat, cholestyramine, nonalcoholic fatty liver disease, phase 2 trial, combination therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846054
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.